Objective To compare the efficacy of covid-19 vaccines between immunocompromised and
immunocompetent people. Design Systematic review and meta-analysis. Data sources …

Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

Abstract Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune
monitoring (CAPTURE)(NCT03226886) is a prospective cohort study of COVID-19 immunity …

Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

Background Patients with cancer are considered a priority group for Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination given their high risk of …

Patients with chronic lymphocytic leukemia (CLL) have an impaired antibody response to
coronavirus disease 2019 (COVID-19) vaccination. Here, we evaluated the antibody …

Patients with hematological malignancies are at increased risk of severe COVID-19
outcomes due to compromised immune responses, but the insights of these studies have …

Objectives To determine whether time elapsed since the second injection of the Pfizer-
BioNTech BNT162b2 mRNA vaccine was significantly associated with the risk of covid-19 …

In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA
vaccination on COVID-19 disease incidence and outcomes in patients with hematologic …

Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against coronavirus disease 2019 (COVID-19), especially in …